Oct 17 2012
Food and Drug Administration officials said Monday that more people may be at risk as a result of contaminated drugs made by a Massachusetts compounding pharmacy.
The New York Times: FDA Warns Of Further Risk From Tainted Drugs
Health officials are warning that more people may be at risk from contaminated drugs made by a Massachusetts company linked to a growing meningitis outbreak (Grady and Tavernise, 10/15).
The Wall Street Journal: New Drugs Tied To Meningitis Outbreak
The Food and Drug Administration said Monday that two additional drugs may be linked to the multistate fungal meningitis outbreak stemming from steroid injections made by a compounding pharmacy in Massachusetts. The FDA said that a cooling solution made by NECC called cardioplegia, used in heart surgery, and a second injected steroid called triamcinolone acetonide now may be involved in the outbreak (Burton, Martin and Rockoff, 10/15).
|
 This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|
Neuroactive drugs show promising anti-glioblastoma effects in preclinical trials